 |
인쇄하기
취소
|
HIRAS to evaluate economic effectiveness of antihypertensive agents
The Health Insurance Review Assessment and Services (HIRAS) said it plans to start re-evaluating the cost effectiveness of insurance-covered antihypertensive drugs under its consultation with the Health Ministry.
The agency said on February 18 that the government will carefully review the industry’s opinions from the Korea Pharmaceutical Manufacturers Association and Korean Research based In...
The agency said on February 18 that the government will carefully review the industry’s opinions from the Korea Pharmaceutical Manufacturers Association and Korean Research based In...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.